Benzoyl peroxide/clindamycin low dose - Ortho Dermatologics

Drug Profile

Benzoyl peroxide/clindamycin low dose - Ortho Dermatologics

Alternative Names: Acanya Gel; BenzaClin Topical Gel; Clin-BPO 2.5%; clindamycin phosphate 1% and benzoyl peroxide 5%; Clindamycin phosphate 1.2% and benzoyl peroxide 2.5%; Clindamycin phosphate 1.2% and benzoyl peroxide 3.75%; ONEXTON Gel

Latest Information Update: 30 Jan 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Arcutis Pharmaceuticals
  • Developer Ortho Dermatologics
  • Class Antiacnes; Antibacterials; Benzoic acids; Lincosamides; Oxidants; Small molecules
  • Mechanism of Action Keratinocyte inhibitors; Protein 50S ribosomal subunit inhibitors; Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Acne vulgaris

Most Recent Events

  • 26 Oct 2017 Perrigo settles patent litigiation against Valeant Pharmaceuticals for an Abbreviated New Drug Application for the generic version of Onexton® gel (clindamycin phosphate 1.2% and benzoyl peroxide 3.75%) in USA
  • 27 Jul 2017 Valeant Pharmaceuticals International acquired Ortho Dermatologics in 2011 and changed the name of the later to Valeant Dermatology. Subsequently, in July 2017, it was rebranded to Ortho Dermatologics
  • 22 Sep 2015 Generic equivalent available in USA for Acne vulgaris
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top